SummaryBoric acid, as alias name as orthoboric acid, is a white, crystalline compound that is used for various purposes, including as an antiseptic, insecticide, and flame retardant . Also, It has been used for medical purposes for over 100 years and is available in many countries, including the United States. It is typically used as an antiseptic for minor cuts and burns, as well as for certain vaginal infections. Boric acid is also used in some prescription medications for the treatment of eye infections. It was first prepared by Wilhelm Homberg from borax, by the action of mineral acids, and was given the name sal sedativum Hombergi ("sedative salt of Homberg"). Its exact mechanism of action is not fully understood. But it is believed that boric acid works by disrupting the cell membranes of fungi and bacteria, leading to cell death. And It is important to note that boric acid can be toxic if ingested or absorbed through the skin in large amounts. Therefore, it should only be used as directed by a healthcare professional or as indicated on the product label. |
Drug Type Small molecule drug |
Synonyms hydrogen borate, orthoboric acid |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (30 Jun 2012) |
Regulation- |
Molecular FormulaBH3O3 |
InChIKeyKGBXLFKZBHKPEV-UHFFFAOYSA-N |
CAS Registry10043-35-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Periodontitis | Phase 2 | IN | 31 Jul 2015 | |
Abortion, Spontaneous | Phase 2 | CA | 30 Apr 2014 | |
Candidiasis | Phase 2 | CA | 30 Apr 2014 | |
Cysts | Phase 2 | CA | 30 Apr 2014 | |
Endometritis | Phase 2 | CA | 30 Apr 2014 | |
Gonorrhea | Phase 2 | CA | 30 Apr 2014 | |
Secondary infection | Phase 2 | CA | 30 Apr 2014 | |
Surgical Wound Infection | Phase 2 | CA | 30 Apr 2014 | |
Uterine Cervical Dysplasia | Phase 2 | CA | 30 Apr 2014 | |
Bacterial Vaginosis | Phase 2 | CA | 01 Apr 2014 |